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X-Ray based Lung Function 
measurement–a sensitive 
technique to quantify lung function 
in allergic airway inflammation 
mouse models
C. Dullin1,2,*, M. A. Markus3,*, E. Larsson2, G. Tromba2, S. Hülsmann4 &  F. Alves1,3,5
In mice, along with the assessment of eosinophils, lung function measurements, most commonly 
carried out by plethysmography, are essential to monitor the course of allergic airway inflammation, 
to examine therapy efficacy and to correlate animal with patient data. To date, plethysmography 
techniques either use intubation and/or restraining of the mice and are thus invasive, or are limited 
in their sensitivity. We present a novel unrestrained lung function method based on low-dose planar 
cinematic x-ray imaging (X-Ray Lung Function, XLF) and demonstrate its performance in monitoring 
OVA induced experimental allergic airway inflammation in mice and an improved assessment of the 
efficacy of the common treatment dexamethasone. We further show that XLF is more sensitive than 
unrestrained whole body plethysmography (UWBP) and that conventional broncho-alveolar lavage and 
histology provide only limited information of the efficacy of a treatment when compared to XLF. Our 
results highlight the fact that a multi-parametric imaging approach as delivered by XLF is needed to 
address the combined cellular, anatomical and functional effects that occur during the course of asthma 
and in response to therapy.
Lung diseases such as asthma, emphysema and chronic obstructive pulmonary disease (COPD) continue to be 
a major burden of public health and show an increasing number of incidences worldwide. Especially asthma 
is a heterogeneous disease which occurs in several different forms and severity1. This is also reflected in the 
strong variations in the efficacy of current treatments among different patients. Due to the complex immunolog-
ical nature of asthma and the rapid change of symptoms, preclinical research with in-vivo experimental animal 
asthma models is inevitable. Mouse asthma models, such as the ovalbumin (OVA) induced acute allergic inflam-
mation, have facilitated a better understanding of the interactions in asthma, but have also revealed that many 
drugs that were successfully tested in mice failed in clinical trials. This is not only related to the immunological 
and physiological differences between mice and humans but also to the challenges a small organism such as the 
mouse presents for imaging and measurement of common hallmarks of asthma2. Thus, histology and cell based 
approaches such as cell count in broncho-alveolar lavage (BAL) are largely used, but how these features relate 
to the impairment of lung function is not well understood. In order to address lung function in mice, plethys-
mography techniques are usually applied, which either require intubation or restraining of the mouse3, adding 
the influence of stress to the results, or - in the case of unrestrained whole body plethysmography (UWBP) - are 
limited in their predictive power due to a lack in sensitivity4. Improved or novel small animal lung function 
measurement techniques are thus fundamentally needed, above all because this parameter is the most relevant 
in humans. New treatments are of little use if they cannot be reliably tested for improvement of lung function. 
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Accurate lung function data in mice, in particular in response to novel therapeutic strategies, may allow a better 
preclinical evaluation of drug efficacy as well as a better comparison with patient data.
Here we present a novel lung function measurement approach utilizing low dose planar cinematic x-ray imag-
ing, which we designate “X-Ray Lung Function” [XLF]. By correlating the results with histology, BAL, synchro-
tron phase contrast CT and UWBP we demonstrate that XLF is easy to use in vivo and shows a significantly higher 
sensitivity than UWBP for the reliable assessment of experimental allergic airway inflammation and the efficacy 
of dexamethasone treatment.
Results
General approach of XLF. In order to depict alterations in lung function in-vivo, XLF uses low dose pla-
nar cinematic radiography of the chest region of unrestrained isoflurane anesthetized mice. We performed the 
technique with the Quantum FX CT (Perkin Elmer), but in principal any x-ray tube with an attached camera and 
anesthesia could be used. The CT produces a movie of 2D radiographs capturing 34 s of the chest movements 
during breathing, depicting the x-ray transmission of the chest area. By slightly modifying the isoflurane concen-
tration, the breathing frequency for each mouse was adjusted to roughly one breathing event in 1400 ms. In the 
generated x-ray movies, regions of interest (ROI) were placed over the left and right lung lobe at the time point of 
maximum contraction. For calibration purposes a region of interest was also placed in an area outside the mouse 
(ROIBkg) (Fig. 1a). The average x-ray transmission is measured in each frame of the movie for both the ROI and 
ROIBkg (Supplementary Figure S1). The x-ray transmission function (XTF) over time describes the difference of 
these values normalized by the average background signal (ROIBkg), in order to account for variations in intensity 
fluctuations of the x-ray tube (Supplementary Figure S1):
=  −

 _XTF(t) ROI(t) ROI (t) /average ROIBgk Bgk
In order to account for slight drifts in the x-ray transmission function, moving average filtering (range 200) was 
applied and the best fitting polynomial function of an order of 2 was calculated (PolyBgk) and subtracted from XTF. As 
the XTF represents a ratio between the x-ray transmission of the chest and the background it is without a physical unit.
Because we adjusted the breathing frequency to one breathing event in 1400 ms and we captured movies of 
34 s, the XTF of each mouse contains about 21 breathing cycles (Supplementary Figure S1). Each breathing cycle 
was parameterized and the average of all cycles within the captured time frame was used to characterize the lung 
function of the mouse.
We applied the technique on an OVA induced experimental allergic airway disease mouse model mimicking 
severe acute asthma (SAA), consisting of 2 sensitization steps and 4 challenges. PBS sensitized and challenged 
mice were used as controls (CN). Treated mice received dexamethasone intraperitoneally (i.p.) 1 h before each 
challenge (SAA-DEX) (Supplementary Figure S2). All mice were gender and age matched and were analyzed on 
day 28 (before the 1st OVA challenge) and on day 35 (2 days after the last challenge). Figure 1b shows two repre-
sentative breathing cycles in a XTF of a SAA mouse (red), a CN mouse (blue) and a dexamethasone treated SAA 
mouse (green). Clear differences in the XTF-curves can be seen between SAA, DEX treated SAA and CN: XLF 
of the SAA mouse displayed a strong reduction in the area under the curve due to the lower air-to-soft-tissue 
ratio within the lung at peak inspiration and an asymmetric shape of the breathing event with a shorter time to 
Figure 1. Breathing modulates the x-ray transmission at the chest region over time. (a) shows an 
exemplified radiograph: the average x-ray transmission function over time (XTF) is measured in a region of 
interest of the lung (ROI) and normalized by the background intensity (ROIBgk); and (b) shows exemplary 
two breathing cycles of a healthy control animal CN (blue curve); a mouse from the severe acute airway 
inflammation model (SAA) two days after the last challenge (red curve) and a mouse from the same model that 
had been treated with dexamethasone before each challenging step (SAA-DEX, green curve). The SAA mouse 
demonstrates a strong reduction in the area under the curve due to the lower air content within the lung at peak 
inspiration and an asymmetric shape of the breathing event with a shorter time to peak. The treated mouse 
(SAA-DEX) shows XTF properties comparable to those obtained in the healthy control mouse CN.
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peak. The treated mouse (SAA-DEX) showed XTF properties comparable to those obtained in the healthy control 
mouse CN.
Quantitative parameters of XLF. In order to quantify the differences in the XTFs among the examined 
groups of mice, we parameterized the XTF curves. For this purpose we first identified breathing events within 
the XTF curves by calculating intersection points of the XTF curve and a line at the level of the average XTF+ 
33% of the standard deviation of the XTF (Supplementary Figure S1). Breathing peaks were identified as intervals 
between two successive intersection points of this line with the XTF curve, where all values are above the level of 
the scan line. Each breathing peak was approximated with a third order polynom P = b2*(x-b1)^3-b3*(x-b1)^2-b4
*(x-b1)+ b5. The average of each parameter (b1-b5) over all breathing cycles is calculated and used to characterize 
the lung function in each particular scan. As the XTF is without physical unit, the parameters bi are also unitless.
B1 describes the shift of the position of the breathing peak maximum and is therefore a measure of the change 
in the ratio between inhalation and expiration time. A reduction in the relative inhalation time corresponds to 
an increase in b1. As shown in Fig. 1b, the representative XTF of a SAA mouse demonstrates an asymmetric 
shape of the breathing peaks with a shift of its maximum to the left and therefore an increase in b1. This is most 
likely related to the decreased elasticity of the asthmatic lung causing the common effect of expiratory airflow 
limitation5.
B2 and b4, as factors for the linear and cubic term of the polynom, both account for asymmetry in the XTF. 
Besides differences in the ratio between the inhalation and exhalation time, they also reflect changes in the slope 
of decay of the XTF in the exhalation period.
B3, as the factor of the quadratic term of the polynom, describes the ‘steepness’ of the breathing peak which is 
dramatically reduced in SAA lungs. This means that the peak is flatter due to a reduced difference in x-ray trans-
mission between inspiration and expiration. This could be caused by two possible effects, an increased soft-tissue 
content in the lung and/or a reduced amount of inhaled air. B3 thus describes the dynamic of the gas exchange.
B5, as the absolute term of the polynom, represents the value of the peak maximum. The peak maximum rep-
resents the maximum air content present in the lung. A high maximum indicates more air in the lung.
B3, in combination with b5, thus describe the area under the curve, meaning how much air is transported in 
which time. High b3 and b5 values indicate a faster transport of a higher amount of air, as found in healthy mice. A 
reduction in b3 and b5 is related to lower air content and a longer exchange time and is thus related to an increase 
in soft-tissue due to the swelling of the airways, both hallmarks of asthma, which both lower the x-ray penetra-
tion. If b5 is unchanged, but b3 is reduced, this would mean a reduction in air flow only and could be an indication 
for a loss of elasticity in the absence of inflammation/oedema.
In addition, the parameter tin[%] was measured, indicating the time that the XTF needs to reach its maximum 
as percentage of the total length of a breathing event. This parameter more accurately represents the asymmetric 
behavior of the duration of inspiration and expiration in asthma. As shown in Fig. 1b, in the presence of allergic 
inflammation (SAA) the XTF is asymmetric and shows a reduced tin[%].
As detailed below, the parameters b1, b3, b5 and tin[%] showed alterations of the lung function in the presence 
of allergic inflammation. B1-b4 were changed during bronchoconstriction as a result of exposure to methacholine.
XLF is a reliable in-vivo lung function measurement method and more sensitive than UWBP. 
To validate the performance of XLF, three groups of mice were analyzed 2 days after the last challenge at the acute 
time point of the disease: healthy controls (CN, N = 6), mice from an OVA induced severe acute airway inflam-
mation model (SAA, N = 6) and mice that received dexamethasone 1 h before each OVA challenge (SAA-DEX, 
N = 6).
XLF shows highly significant differences between CN and SAA mice (p < 0.05) in the parameters b1, b3, b5 
and tin[%]: SAA mice are characterized by a higher b1 and lower tin[%], indicating a shorter relative inspira-
tion period. Furthermore, SAA mice display reduced b3 and b5, pointing to decreased x-ray transmission of 
the lung region caused by a lower amount of air and a reduced air flow. The combination of both parameters 
point to reduced elasticity and increased soft tissue content and/or oedema, related to the inflammation in SAA 
(Fig. 2). A significantly increased b1 and decreased b3 was found in the dexamethasone treated asthmatic mice 
SAA-DEX when compared to the healthy controls CN, however less pronounced than in the untreated SAA 
mice. Interestingly, b5 is not significantly reduced in SAA-DEX animals when compared to CN, suggesting that 
the treatment has resulted in a reduction of the swelling. XLF was therefore sensitive enough to demonstrate that 
dexamethasone acts predominantly on the inflammatory aspects of the disease and less on the elasticity of the 
lung. XLF measurements directly before challenge (i.e. after sensitization) revealed no difference compared to 
controls in all parameters (data not shown).
UWBP reveals the same trend in tin[%] as XLF, but the differences are not significant (Fig. 2). The UWBP 
parameters MaxSlope and MinSlope indicate a reduction in the airflow of SAA and SAA-DEX in comparison to 
CN, which corresponds to the observed decrease in x-ray transmission b3 and b5 in XLF (Fig. 2). Interestingly, 
this effect was more pronounced in dexamethasone treated mice than in SAA mice and was significantly different 
to CN.
To show that XLF is able to make repeated measurements in the same animal we repeated the experiment with 
another cohort of mice (SAA, N = 5; CN, N = 5) and performed a second challenge after a recovery time of 19 
days from the initial challenges. XLF was able to detect significant differences in parameters b1 and tin[%] between 
SAA and CN after rechallenge. Parameters b3 and b5 were not significantly different, suggesting that a single 
rechallenge led to a weaker inflammatory reaction and/or oedema as the initial 4 challenges (data not shown).
XLF is able to measure airway responsiveness to methacholine. Airway responsiveness to meth-
acholine was determined 2 days after the last challenge. Both CN and SAA reacted in changed parameters in 
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Figure 2. Comparison of XLF parameters with UWBP for healthy mice (CN), mice with severe acute 
airway inflammation (SAA) and dexamethasone treated mice of the same model (SAA-DEX). XLF 
shows significant differences between CN and SAA for b1, b3, b5 und tin. The treated mice (SAA-DEX) show 
intermediate values suggesting an inefficient treatment in terms of lung function. UWBP failed to display 
significant differences in all parameters between CN, SAA and SAA-DEX mice, indicating that our XLF 
approach - as the only other in-vivo LF method used in this study - has a higher sensitivity and specificity than 
in-vivo UWBP. Statistical significance difference of the results is indicated by (*p < 0.1, **p < 0.05).
Figure 3. Airway responsiveness to methacholine as measured by XLF. Relative change of XLF parameters 
to baseline values are shown for SAA and CN in dependence of increasing concentrations of methacholine 
(0, 3, 10, and 50 mg/ml). In SAA animals b1, b2 and b4 are significantly affected by a lower concentration of 
methacholine (10 mg/ml) than CN (50 mg/ml) relative to 0 mg/ml (**p < 0.05).
www.nature.com/scientificreports/
5Scientific RepoRts | 6:36297 | DOI: 10.1038/srep36297
dependency of the concentrations of methacholine. There was higher airway reactivity in SAA mice compared 
with CN mice as measured by a stronger relative increase of parameters b1, b2, b3 and b4 (Fig. 3). As b2 and b4 
reflect the asymmetry of the XTF curve, their change upon bronchoconstriction most likely displays the spasms 
caused by narrowing of the bronchi. This result shows that XLF is able to reliably measure airway responsiveness.
XLF in comparison to BAL, histology and pSRμCT. In order to validate the findings of XLF, the results 
were correlated to data obtained by BAL, synchrotron phase contrast CT (pSRμ CT) and histology. The parameters 
measured by each technique are described in more detail in Online Methods.
BAL is a common tool for diagnosis of lung inflammation and analysis of differential cell counts in BAL fluid 
is standard for both preclinical and clinical routine. As shown in Fig. 4, the total amount of cells in the BALs 
of SAA animals is significantly increased compared to controls (CN) and this increase is mostly related to an 
increase in eosinophils, as is characteristic for this OVA induced asthma mouse model. Moreover, the dexametha-
sone treated mice (SAA-DEX) showed slightly less but still a high amount of eosinophils compared to the controls 
(CN), indicating that based on the BAL results the dexamethasone treatment is only partly effective.
A characteristic asthma related swelling of the airways was verified by pSRμ CT on in-situ lungs, demon-
strating a significant increase in the soft-tissue vol.ratio of the lungs in SAA mice compared to CN (Fig. 4 and 
Supplementary Figure S3). These structural alterations could also be seen by histology of paraffin lung sections 
stained by H&E and PAS. HE and PAS scores were obtained and showed an increase in the presence of asthma, 
consistent with an increase in cell infiltration and mucus (Fig. 4 and Supplementary Figure S4). The dexametha-
sone treatment demonstrated a significantly reduced inflammation in the lungs as demonstrated by a diminished 
PAS-score of SAA-DEX in the histology and an intermediate soft-tissue vol.ratio of SAA-DEX between CN 
and SAA. These results, together with the consisting high eosinophil number in SAA-DEX mice, indicate that 
the allergic reaction has not completely resolved after dexamethasone treatment. This is further supported by 
the increased relative δ-value in pSRμ CT of SAA-DEX mice in comparison to CN (Fig. 4). The δ-value, the real 
part of the complex refractive index, is a parameter that characterizes the composition of the lung soft-tissue6. 
A lower δ-value would point to a higher water content; instead, the here observed increased δ-values indicate 
an effect of an elevated amount of cells in SAA and SAA-DEX rather than mucus production. As the rel. δ -value 
is not reduced in the same way as the soft tissue vol.ratio for SAA-DEX lungs, this suggests that the treatment 
suppresses the swelling of the airway walls without affecting the composition of the tissue.
Figure 4. Correlation of XLF and UWBP to ex-vivo techniques BAL, pSRμCT, and histology for healthy 
mice (CN), mice with severe acute airway inflammation (SAA) and dexamethasone treated mice of the 
same model (SAA-DEX). The analysis of BAL shows a significant increase in total cell number and in the 
relative amount of eosinophils (EOS[%]) in SAA mice when compared to CN mice, verifying the presence of 
asthma. SAA-DEX still reveals an increased number of eosinophils suggesting inefficient treatment. pSRμ CT 
suggests a strongly increased soft-tissue vol.ratio within the lungs of SAA and intermediate values for SAA-
DEX mice. SAA and SAA-DEX lungs show no difference in the rel. δ -value. Histology shows an increased 
amount of infiltrating cells in SAA (HE-score) and an increased mucus production (PAS-score), SAA-DEX 
mice demonstrate intermediate results, suggesting only partially successful treatment. Statistical significance 
difference of the results is indicated by (*p < 0.1, **p < 0.05).
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Influence of age and sex on XLF. In order to evaluate the influence of sex and age on the XLF results, 72 
female BALB/c mice divided into 3 age groups (younger than 7 weeks N = 16, between 7 and 9 weeks old N = 27 
and older than 9 weeks N = 29) as well as 37 female and 32 male mice older than 7 weeks were analyzed. We 
found a significantly increased b5 and a significantly lowered tin[%] in the male compared to the female mice 
(Supplementary Figure S5), most likely due to the larger body size of age matched males. Additionally, b1, b3 and 
b5 show significant variations with the age of the analyzed mice (Supplementary Figure S5). The magnitudes of 
these variations are lower than the respective effect sizes between CN and SAA and would therefore not interfere 
with the detection of hallmarks of asthma. However, to minimize variability and due to previous reports on sex 
specific differences in the severity of asthma7, it is recommended that XLF be used with gender and age-matched 
mice, as was the case for all other experiments in this study.
Discussion
We demonstrated that our novel lung function approach XLF, using low dose cinematic planar x-ray imaging, 
allows the distinction of mice with severe allergic airway inflammation (SAA) from healthy mice (CN), and the 
assessment of the efficacy of dexamethasone in SAA mice (SAA-DEX). We introduced quantitative parameters 
(b1–b5 and tin[%]) based on curve fitting of the breathing events in the x-ray attenuation over the mouse chest. 
SAA demonstrated a reduced tin[%]-value, indicating a shorter relative inspiration time in asthma, and a reduced 
b3-value depicting lower air-flow, as well as a reduced b5, suggesting a higher soft-tissue-to-air ratio in asthma. 
These results are paralleled by the strong increase in eosinophils and total cells observed in BAL and by histology. 
Together with the strongly increased soft-tissue vol.ratio and rel. δ-value demonstrated by SRμ CT, this indicates 
a modification in the relation between water and cells within the lung.
Furthermore, we were able to show that XLF was sensitive enough to measure significant differences in 2 
parameters of rechallenged SAA versus CN animals after 19 days of recovery from the acute inflammatory 
response. We could also show that XLF is capable of determining airway responsiveness to methacholine. 
Methacholine challenge tests are often performed by the forced oscillation technique (FOT), a very invasive and 
terminal method, where the mice are tracheotomized and artificially ventilated. By contrast, XLF can reliably 
determine airway resistance to methacholine challenge non-invasively and non-terminally. Both these findings, 
the ability to rechallenge over time and to measure airway resistance non-invasively, demonstrate that XLF allows 
longitudinal studies in the same animal. This is of immense importance as it dramatically reduces the numbers 
of animals needed and increases the predictive value of the results due to the absence of inter- subject variations.
Analysis of the influence of age and sex of the mice on XLF indicated significant differences for both factors, 
underlying the sensitivity of XLF. While these differences were much lower than those observed between SAA 
and CN, age and gender effects on XLF can be avoided by using age and gender matched mice.
For comparison with other lung function methods, we used UWBP over restrained plethysmography, as the 
latter is much more invasive and places a substantial stress on the animal, which may influence lung function 
data8. Compared to XLF, UWBP struggled with the higher breathing frequency of the non-anesthetized mice and 
revealed only faint differences in the lung function between treated and healthy mice. tin obtained by UWBP is 
the only parameter that can be directly related to tin in XLF and essentially indicates the same trend (a reduction 
in SAA), but could not reach significance. Although UWBP is less invasive because it does not require anesthesia, 
it became obvious that the method is less sensitive than XLF. One potential reason is the problem of explorative 
behavior which is associated with higher variability of respiratory cycles. Moreover, the lower breathing frequency 
in the anesthetized mice compared to the non-anesthetized mice used for UWBP, may contribute to the enhanced 
sensitivity of XLF. In contrast to UWBP, XLF is also influenced by structural changes within the lung that occur in 
allergic airway inflammation. This may further explain the increased sensitivity of XLF in discriminating between 
CN, SAA and SAA-DEX in-vivo compared to UWBP.
The minor reduction of eosinophils in the dexamethasone treated mice as well as the only marginal differ-
ences (non-significant data) in morphological changes from SAA to SAA-DEX judged by histology and pSRμ CT, 
may suggest that the dexamethasone treatment is largely inefficient. XLF, on the one hand, shows that b5 is not 
significantly reduced when compared to controls, while b1 and b3 are. This suggests that dexamethasone resulted 
in a reduction of inflammation but no improvement of the elasticity of the lung. XLF thus produced additional 
information on the efficacy of the treatment that could not be extracted from any of the other techniques. By 
comparison of these readouts we conclude that for evaluating treatment efficacy it is of crucial importance to con-
sider and assess all aspects – cellular, anatomical and functional alterations. XLF may advance such a multimodal 
approach as it allows a very sensitive evaluation of functional alterations in lung disease in-vivo over time and can 
therefore be used to follow the course of the disease or the response to a treatment.
In summary, we demonstrated the benefits of XLF, a novel highly sensitive in-vivo lung function measurement 
method for mouse lung disease models. Due to the combined influence of functional and morphological altera-
tions on the measured parameters, XLF provides additional information that can help to better understand the 
pathomechanism of lung disease as well as the effect of novel therapies.
Methods
Animal models for allergic airway disease. Female BALB/c mice (4–6 weeks old) were purchased from 
Charles River Laboratories and maintained with ad libitum food and water. An OVA induced experimental aller-
gic airway disease model was generated to mimic severe acute asthma (SAA) as described by Dullin et al.6. Briefly, 
mice were sensitized twice with 50 μ g OVA i.p. and i.n. on days 0 and 14 and then challenged 4 times on days 28, 
29, 30, and 33 with 250 μ g OVA i.n. Controls received phosphate-buffered saline (PBS, ThermoFisher Scientific) 
instead of OVA at the same time points (CN). Moreover, a SAA-group was treated with 4 mg/kg dexamethasone 
(Ratiopharm) i.p., 1 h before each challenge (SAA-DEX). For rechallenging experiments the mice were left for 19 
days to recover from the acute inflammatory reaction before one re-exposure with 250 μ g OVA i.n.
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XLF. In order to address lung function in-vivo, low dose planar cinematic x-ray images were acquired using an 
in-vivo microCT (QuantumFX, Perkin Elmer) operated with the following parameters: field of view 20 × 20 mm2, 
x-ray tube voltage 90 kVp and tube current 40 μ A. 1024 images were acquired continuously with a rate of 30 
images per second (Supplementary Movie 1). Mice were scanned unrestrained but under isoflurane anesthesia 
(~2% isoflurane in 2 l oxygen per min). The x-ray transmission over time in the lung area and in a background 
region were measured using Fiji9 and exported as text files. The developed quantification algorithm was imple-
mented in Matlab R2011b (Mathworks).
Determination of airway responsiveness to methacholine. For determination of responsiveness to 
methacholine by XLF, mice were anesthetized with isoflurane and placed in the microCT scanner as described 
under the previous point. An aerosol chamber (Aeroneb Pro, Inspiration Medical) was connected to the anes-
thesia tube via a T-fitting, so that the aerosolized methacholine was transported to the mouse with the isoflu-
rane gas stream. XLF data were obtained at baseline and immediately following 10 sec nebulization of increasing 
concentrations of methacholine (0 mg/ml; 3 mg/ml; 10 mg/ml; 50 mg/ml), with 5 min intervals between each 
concentration.
Unrestrained whole body plethysmography (UWBP). Ventilation was measured by UWBP, measur-
ing pressure changes resulting from the warming of the inspired air and cooling during expiration10. Mice were 
placed in a plexiglas chamber (1.2 L volume, custom made) that was connected to a differential low-pressure 
transducer (model DP1 03, Validyne Engineering, Northridge, CA). The second channel of the pressure trans-
ducer was connected to a reference chamber. The bias flow in the chamber was 200 ml/min, introduced by the 
suction of a CO2-sensor (Dräger). The pressure transducer was connected to a sine wave carrier demodulator 
(CD-15, Validyne Engineering). A MiniDigi1A (Molecular Devices) was used for digitization (1 kHz sampling 
rate) and storage on a PC Notebook (Fujitsu) using AxoScope Software (Molecular Devices). For analysis, pres-
sure fluctuations were imported into LabChart 8 Software (ADInstruments) and offline band-pass filtered (0.5–20 
Hz). The Peak Analysis Module was used to detect pressure maxima and calculate peak amplitude [a.u.], respira-
tory rate [BPM] and relative inspiratory time (tin[%]). Max- and MinSlope parameter, were derived as measure 
for chamber flow as the first derivative from pressure trace. Because animals were allowed to explore the chamber 
freely, and thus, some pressure changes resulted from sniffing behavior, we analyzed a period of 2 min after an 
initial period of adaptation (3 min).
Use of experimental animals. All animal in vivo procedures were performed in compliance with the 
guidelines of the European Directive (2010/63/EU) and the German ethical laws and were approved by the 
administration of Lower Saxony, Germany (Nr. G15.1747).
In-situ lung imaging using Synchrotron phase contrast micro CT (pSRμCT). For detailed 3D 
depiction of asthma related anatomical alterations of the lung tissue, mice were sacrificed, lungs were kept in-situ 
and inflated with air at a constant pressure of 30 cm water column and the whole body was embedded in 1% 
agarose gel in cylindrical plastic containers as described before11. The samples were then imaged at the SYRMEP 
beamline (Synchrotron Light Source ‘Elettra’, Trieste, Italy) using the protocol described by Dullin et al.11. A 
sample-to-detector distance of 30 cm was chosen to allow for the formation of phase effects. Prior to 3D recon-
struction a single distance phase retrieval algorithm (TIE-Hom, Gureyev T. et al.12) was applied resulting in the 
generation of 3D data sets with a voxel size of 9 × 9 × 9 μ m3 predominately expressing the distribution of the 
δ -part of the complex refractive index within the sample (about 10 times more sensitive in lungs than using stand-
ard absorption based CT13). Quantification of the lung structure was performed by placing eight non-overlapping 
volumes-of-interests (VOIs) of 2 × 2 × 2 mm3 uniformly distributed in the peripheral region of the lungs in order 
to analyze the relative soft-tissue content of each VOI (vol.ratio) using threshold based segmentation to dis-
criminate between air and non-air (soft-tissue and liquids). In addition, the average δ-value of the soft-tissue 
compartment was calculated. As the performed imaging cannot discriminate between liquid (such as mucus) 
and cells, the average δ-value is affected by the prevailing mixture of these components in any given mouse lung 
and can therefore be used as an additional parameter as demonstrated by Dullin et al.6. For 3D visualization and 
quantification the software Scry v6.0 (Kuchel & Sautter GbR) was used.
Histology. Lungs were excised either after BAL or pSRμ CT, fixed in 10% buffered formalin and embed-
ded in paraffin. 3 μ m-thick paraffin lung sections containing main stem bronchi were stained with either 
hematoxylin-eosin (H&E) for 2 min or with periodic acid for 5 min followed by Schiffs reagent for 15 min (PAS). 
An Axioskop 2 (Carl Zeiss Microscopy GmbH) microscope in combination with a Leica DC 100 camera was 
used for visualization of the stained sections. Sections were scored in a blinded fashion from 0 to 3 to address the 
amount of infiltrating immune cells seen in H&E (designated HE-score) and the amount of mucus producing 
goblet cells seen in the PAS staining (designated PAS-score), with 0 = no infiltrating cells and no mucus, 1 = low 
infiltrating cell count and mucus, 2 = medium infiltrating cell count and mucus, 3 = high infiltrating cell count 
and mucus.
Bronchoalveolar Lavage (BAL). Following lung function measurement 48 hrs after the last OVA chal-
lenge, mice were sacrificed. BAL was performed by washing the airways gently three times with 500 μ l of 2% FCS/
PBS after exposing and cannulating the trachea. Volumes were pooled and then washed once in the same buffer. 
Recovered cells were counted in a haemocytometer and 3 × 104 cells were used for cytospins followed by Giemsa 
staining (Sigma Aldrich) for differential cell counting using an Axioskop 2 microscope. Values are expressed as 
total cell number and relative amount of eosinophils (EOS[%]).
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Statistical analysis. For statistical analysis, the unpaired Welch t-test for same mean implemented in MS 
Excel 2010 was used with a p-value of 0.1 (*) or a p-value of 0.05 (**) as margins for statistical significance.
Note. Ex-vivo techniques such as histology and broncho-alveolar lavage provide only partial information in 
the analysis of allergic airway inflammation mouse models. While lung function measurements have been per-
formed by plethysmography, this method shows limited sensitivity in allergic airway inflammation. Here we 
introduce a novel method to measure lung function in mice based on cinematic low dose planar x-ray imaging 
(XLF) using an in-vivo small animal microCT. We show that XLF is able to assess lung function in a severe allergic 
airway inflammation mouse model, provides comprehensive information to monitor treatment and is more sen-
sitive than unrestrained whole body plethysmography. XLF can be easily adapted to other CT systems and other 
lung diseases and may therefore be of use to a broad audience.
References
1. Kim, H. Y., DeKruyff, R. H. & Umetsu, D. T. The many paths to asthma: phenotype shaped by innate and adaptive immunity. Nat. 
Immunol. 11, 577–584 (2010).
2. Irvin, C. G. & Bates, J. H. Measuring the lung function in the mouse: the challenge of size. Respir. Res. 4 (1) (2003).
3. Glaab, T., Taube, C., Braun, A. & Mitzner, W. Invasive and noninvasive methods for studying pulmonary function in mice. Respir. 
Res. 8, 63 (2007).
4. Adler, A. Unrestrained plethysmography is an unreliable measure of airway responsiveness in BALB/c and C57BL/6 mice. J. Appl. 
Physiol. 97, 286–292 (2004).
5. Gelb, A. F. & Zamel, N. Lung elastic recoil in acute and chronic asthma. Curr. Opin. Pulm. Med. 8, 50–53 (2002).
6. Dullin, C., Larsson, E., Tromba, G., Markus, A. M. & Alves, F. Phase-contrast computed tomography for quantification of structural 
changes in lungs of asthma mouse models of different severity. J. Synchrotron Radiat. 22 (2015).
7. Chang, H.-Y. S. & Mitzner, W. Sex differences in mouse models of asthma. Can. J. Physiol. Pharmacol. 85, 1226–1235 (2007).
8. Vanoirbeek, J. A. J. et al. Noninvasive and Invasive Pulmonary Function in Mouse Models of Obstructive and Restrictive Respiratory 
Diseases. Am. J. Respir. Cell Mol. Biol. 42, 96–104 (2010).
9. Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012).
10. Drorbaug, J. E. & Fenn, W. O. A barometric method for measuring ventilation in newborn infants. Pediatrics 16, 81–87 (1955).
11. Dullin, C. et al. Functionalized synchrotron in-line phase-contrast computed tomography: a novel approach for simultaneous 
quantification of structural alterations and localization of barium-labelled alveolar macrophages within mouse lung samples. 
J. Synchrotron Radiat. 22, 143–155 (2015).
12. Gureyev, T., Mohammadi, S., Nesterets, Y., Dullin, C. & Tromba, G. Accuracy and precision of reconstruction of complex refractive 
index in near-field single-distance propagation-based phase-contrast tomography. J. Appl. Phys. 114, 144906 (2013).
13. Mohammadi, S. et al. Quantitative evaluation of a single-distance phase-retrieval method applied on in-line phase-contrast images 
of a mouse lung. J. Synchrotron Radiat. 21, 784–789 (2014).
Acknowledgements
This work was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [DU 
1403/1-1], by the ‘EXTREMA’ COST action MP1207, the COST action MP1203 and by the ‘Talents3’ mobility 
fellowship of the Italian region ‘Friuli Venezia Giulia’. The authors thank Sarah Garbode, Christina Malowsky, 
Bärbel Heidrich, Roswitha Streich, Bettina Jeep and Sabine Wolfgramm for technical assistance.
Author Contributions
C.D. has planned the study, performed the experiments, analyzed the XLF, phase contrast CT and histology data 
data) and wrote the publication. M.A.M. has set up the animal model, has provided the biological background 
of the study, has performed the histology and BAL analysis and has contributed to the writing process. E.L. 
has helped to acquire and analyze the phase contrast CT data and contributed to the writing process. G.T. has 
overseen the phase contrast CT data acquisition, has contributed to the CT data analysis and participated in 
writing the article. H.S. has performed the UWBP experiment, analyzed the data and contributed to the writing 
of this publication. F.A. has provided the medical background, has helped in planning the overall study concept, 
has critically reviewed the results and majorly contributed to the writing process.
Additional Information
Supplementary information accompanies this paper at http://www.nature.com/srep
Competing financial interests: The authors declare no competing financial interests.
How to cite this article: Dullin, C. et al. X-Ray based Lung Function measurement–a sensitive technique 
to quantify lung function in allergic airway inflammation mouse models. Sci. Rep. 6, 36297; doi: 10.1038/
srep36297 (2016).
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
This work is licensed under a Creative Commons Attribution 4.0 International License. The images 
or other third party material in this article are included in the article’s Creative Commons license, 
unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, 
users will need to obtain permission from the license holder to reproduce the material. To view a copy of this 
license, visit http://creativecommons.org/licenses/by/4.0/
 
© The Author(s) 2016
